GlassScriptPhysician profile
Deborah Sauer
NPI 1336424316
$3,954.50
in general payments reported to CMS, 2019-2025
13 companies · $1,482 in 2025
The $1,482 reported for 2025 was more than what 92% of Acute Care (Nurse Practitioner) providers received nationally (typical 2025 total: $151).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $712 · 2022: $616 · 2023: $638 · 2024: $507 · 2025: $1,482.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,014 · Travel and Lodging: $613.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,013.83 |
| Travel and Lodging | $613.08 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $1,422.61 | 2021-2025 | Ensite, Tacticath Ablation Catheter, Sensor Enabled, Viewmate |
| Medtronic, INC. | $1,201.96 | 2021-2025 | Linq II, Affera Mapping System, Micra |
| Boston Scientific Corporation | $821.88 | 2021-2025 | Accolade Sr, Lux-Dx Insertable Cardiac Monitor, Emblem Mri S-Icd |
| Irhythm Technologies, INC. | $246.36 | 2022-2024 | Zio Xt Patch, Zio Monitor |
| Janssen Pharmaceuticals, INC | $67.66 | 2021 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $64.51 | 2021 | |
| Merck Sharp & Dohme LLC | $31.72 | 2021-2022 | |
| Novo Nordisk INC | $21.67 | 2025 | Wegovy |
| Bayer Healthcare Pharmaceuticals INC. | $18.99 | 2025 | |
| Actelion Pharmaceuticals US, INC. | $15.71 | 2021 | |
| Cvrx, INC. | $14.44 | 2024 | Barostim Neo System |
| Amgen INC. | $13.55 | 2025 | Repatha |
| Alnylam Pharmaceuticals INC. | $13.44 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Deborah Sauer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.